1. Home
  2. VTAK vs ORIS Comparison

VTAK vs ORIS Comparison

Compare VTAK & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

HOLD

Current Price

$2.08

Market Cap

4.1M

Sector

Health Care

ML Signal

HOLD

ORIS

Oriental Rise Holdings Limited Ordinary Shares

HOLD

Current Price

$0.09

Market Cap

3.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTAK
ORIS
Founded
2002
2014
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
3.7M
IPO Year
2018
2024

Fundamental Metrics

Financial Performance
Metric
VTAK
ORIS
Price
$2.08
$0.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
54.5K
2.5M
Earning Date
11-13-2025
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.00
Revenue
$730,000.00
$12,317,000.00
Revenue This Year
$822.86
N/A
Revenue Next Year
$168.42
N/A
P/E Ratio
N/A
$233.06
Revenue Growth
82.96
N/A
52 Week Low
$1.49
$0.07
52 Week High
$15.68
$2.85

Technical Indicators

Market Signals
Indicator
VTAK
ORIS
Relative Strength Index (RSI) 42.71 30.50
Support Level $2.00 $0.07
Resistance Level $3.06 $0.11
Average True Range (ATR) 0.29 0.01
MACD -0.04 -0.00
Stochastic Oscillator 12.07 34.59

Price Performance

Historical Comparison
VTAK
ORIS

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).

Share on Social Networks: